688298.SS SHH
Zhejiang Orient Gene Biotech Co., Ltd
1W: +2.0%
1M: +0.9%
3M: +1.1%
YTD: -22.0%
1Y: -32.0%
3Y: -49.3%
5Y: -81.0%
¥19.37 ($2.89)
+0.45 (+2.38%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥3.9B ($582.3M)
52W Range17.03-28.99
Volume2,085,650
Avg Volume1,541,452
Beta0.83
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOXiao Liang Fang
Employees2,068
SectorHealthcare
IndustryMedical - Specialties
IPO Date2020-02-05
Websiteorientgene.com
No. 3787, East Yangguang Avenue
Huzhou, SH 313300
CN
Huzhou, SH 313300
CN
86 57 2522 8781
About Zhejiang Orient Gene Biotech Co., Ltd
Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagnosis; and quantum-beads multiplex. Zhejiang Orient Gene Biotech Co., Ltd was founded in 2005 and is based in Huzhou, China.
Latest News
No recent news
Recent Insider Trades
No insider trades found